Hügle-Dörr, Barbara Dr.Universität HeidelbergHeidelberg
Refine publication list
Year of publication
Type of Publication
Language
Co-author (Univ. of Heidelberg)
- Hillengaß, Jens (2)
- Seckinger, Anja (2)
- Hose, Dirk (2)
- Möhler, Thomas (1)
- Tichy, Diana (1)
- Schurich, Bärbel (1)
- Hielscher, Thomas (1)
- Pritsch, Maria (1)
- Kunz, Christina (1)
- Neben, Kai (1)
- Luntz, Steffen P. (1)
- Wuchter, Patrick (1)
- Rabold, Bernhard (1)
- Giesen, Nicola (1)
Co-author (external)
Publications in heiBIB 
- Goldschmidt, Hartmut: Response-adapted lenalidomide maintenance in newly diagnosed myeloma : results from the phase III GMMG-MM5 trial / Hartmut Goldschmidt, Elias K. Mai, Jan Dürig, Christof Scheid, Katja C. Weisel, Christina Kunz, Uta … , 7 February 2020. - 13 S.
In: Leukemia, ISSN 1476-5551. 34(2020), 7, Seite 1853-1865
DOI: 10.1038/s41375-020-0724-1
- Huhn, Stefanie: Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trial / S. Huhn, N. Weinhold, J. Nickel, M. Pritsch, T. Hielscher, M. Hummel, U. Bertsch, B. Huegle-Doerr, M… , 15 May 2017. - 5 S.
In: Bone marrow transplantation, ISSN 1476-5365. 52(2017), 8, Seite 1194-1198
DOI: 10.1038/bmt.2017.91
- Mai, Elias K.: Phase III trial of bortezomib, cyclophosphamide, dexamethasone (VCD) versus bortezomib, doxorubicin, dexamethasone (PAd) in newly-diagnosed myeloma / E. K. Mai, U. Bertsch, J. Dürig, C. Kunz, M. Haenel, I. W. Blau, M. Munder, A. Jauch, B. Schurich, T… , 2015
In: Leukemia, ISSN 1476-5551. 29(2015), 8, Seite 1721-1729
DOI: 10.1038/leu.2015.80
